# Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R43/R44)

Source: https://welltoldgrants.com/grants/rfa-hg-21-008-transformative-nucleic-acid-sequencing-technology/  
Official notice: https://www.grants.gov/search-results-detail/332475

> National Institutes of Health offered grants to small businesses. Applications closed on February 1, 2023.

| Field | Value |
|---|---|
| Opportunity number | RFA-HG-21-008 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | February 1, 2023 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.172 |

## Who can apply

- Small businesses

Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

## What the grant funds

The National Human Genome Research Institute intends to promote a new initiative by publishing a Request for Applications to solicit R43/R44 applications for research in the area of Transformative Nucleic Acid Sequencing Technology Innovation and Early Development: The purpose of the RFA is to refocus and emphasize NHGRIs investment in nucleic acid sequencing technology on novel technology innovation and early development. This Notice is being provided to allow potential applicants sufficient time to develop effective collaborations and responsive projects. The FOA is expected to be published in the winter of 2021 with an expected application due date in the summer of 2021.

## Questions people ask

### Is RFA-HG-21-008 still open?

No. It closed on February 1, 2023.

### Who can apply for Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R43/R44)?

National Institutes of Health accepted applications from small businesses. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R43/R44)?

Closed February 1, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### Who has been funded under RFA-HG-21-008?

NIH RePORTER lists 4 projects funded under RFA-HG-21-008 in fiscal 2022 to 2024, at 1 institution.

### Who has won Human Genome Research grants before?

The largest recipients over five fiscal years were The Leland Stanford Junior University, University of Washington, The Broad Institute, Inc. The program made 1,255 awards worth $2.2 billion in that time.